Anilkumar Jangili
Director of Statistical Programming, SpringWorks Therapeutics His expertise spans the entire lifecycle of clinical trials, from design through to FDA submissions, with a deep understanding of regulatory compliance and data integrity.
About this speaker
At SpringWorks Therapeutics, Anilkumar serves as the Director of Statistical Programming, leading the development and execution of the company's data strategy. With a strong focus on clinical trial analysis precision, Anilkumar has used his proficiency in SAS programming and strategic planning to contribute significantly to the delivery of robust clinical reports that meet the highest industry standards. Recognized as an Honored Listee by Marquis Who's Who, Anilkumar is celebrated for his dedication and impactful contributions to the biopharmaceutical field.
With extensive experience in project planning, resource management, and achieving outstanding results while adhering to CDISC standards and Good Clinical Practice (GCP) guidelines, Anilkumar's work has had a profound effect on the clinical research industry. His commitment to compliance standards and effective project execution is critical to the success of clinical trials.
Beyond his technical work, Anilkumar is actively engaged in the broader clinical research community. His thought leadership includes peer reviewing for the American Journal of Cancer Research, judging prestigious awards like the Globee Awards for Leadership, and participating in panels for organizations such as the Society for Clinical Data Management (SCDM) and the Center for Information and Study on Clinical Research Participation (CISCRP). He is also a certified peer reviewer from Elsevier Researcher Academy and has been selected as a judge for the CES Innovation Awards and CLARO Awards.
